Govt To Reduce Dependency On Import For Pharma, Medical Devices

New Delhi : Union Minister for Chemicals and Fertilizers and Health and Family Welfare, Dr Mansukh Mandaviya today said that the government had decided to reduce the dependency on import for pharma and medical devices to meet the critical requirements of the country.

He said that the domestic manufacturing needed to scale up as the country wanted to dominate the world. Its aim is not to be dependent on anyone.

Addressing a press conference the Minister said that currently India had highest manufacturing capacity for generic medicines. In order to increase the production of patented drugs manufacturing in India, both innovation and research is required. To bring more innovation and research, the government is taking various steps and soon the government will announce a policy also in this regard.

This conference will decide the roadmap of Indian Pharma and Indian Medical devices sector for the next 25 years to take India beyond ‘Pharmacy of the World, he said.

Speaking on the occasion, Minister of State, BhagwanthKhuba said that with the growth in pharmaceutical sector, India was aspiring to become a pharmaceutical hub. He further stated that to boost the Indian medical devices sector the country needed to bring new technologies, innovation along with focus on Research and Development activities.

Secretary, Department of Pharmaceuticals, S. Aparna said that Indian Pharmaceutical and Medical Device Sector required collaboration between industries, academia, researchers, regulators and policymakers that would help these two sectors. The government has formulated several mechanisms including empowered group of secretaries, project development cell, PLI schemes, and a conducive policy environment to strengthen the pharma and medical device ecosystems.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore